Biscayne Pharmaceuticals
Miami
About Biscayne Pharmaceuticals
Biscayne Pharmaceuticals, Inc. operates as a biopharmaceutical company that develops therapies based on growth hormone-releasing hormone (GHRH) analogs. The compounds include GHRH antagonists in development for the treatment of cancer, including castrate-resistant prostate cancer, and GHRH agonists for the repair of cardiac damage in heart disease patients. The company was incorporated in 2012 and is headquartered in Miami, Florida.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $11.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2017)
- Website: biscaynepharma.com
- Phone: 305-793-7326
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/biscayne-pharmaceuticals-166683 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.